SEC CIK 1624610
Bitzer John III
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| BNBXview stock → | 1,409,383 | 2019-09-24 |
Position History — BNBX
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — BNBX
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2021-11-01 | Grant / award (derivative) | 19,897 | $0.00 | 19,897 |
| 2021-11-01 | Grant / award (derivative) | 11,689 | $0.00 | 11,689 |
| 2020-05-22 | Grant / award (derivative) | 12,598 | $0.00 | 12,598 |
| 2019-09-24 | Option exercise (out-of-money) (derivative) | 106,197 | $0.00 | 0 |
| 2019-09-24 | Option exercise (out-of-money) | 196,661 | $0.54 | 1,409,383 |
| 2019-05-17 | Grant / award (derivative) | 175,435 | $0.00 | 175,435 |
| 2018-10-17 | Grant / award (derivative) | 12,778 | $0.00 | 12,778 |
| 2018-10-17 | Disposition to issuer (derivative) | 12,778 | $0.00 | 0 |
| 2018-08-31 | Conversion (derivative) | 100,000 | — | 100,000 |
| 2018-08-31 | Conversion (derivative) | 100,000 | — | 100,000 |
| 2018-03-15 | Grant / award (derivative) | 7,204 | $0.00 | 7,204 |
| 2018-03-15 | Grant / award (derivative) | 63,919 | $0.00 | 63,919 |
| 2017-06-28 | Grant / award | 56,819 | $1.76 | 1,212,722 |
| 2016-12-20 | Grant / award (derivative) | 44,787 | $0.00 | 44,787 |
| 2015-12-21 | Grant / award (derivative) | 32,455 | $0.00 | 32,455 |
| 2014-12-22 | Grant / award (derivative) | 36,134 | $0.00 | 36,134 |
| 2014-11-20 | Open-market buy (derivative) | 76,923 | $0.01 | 76,923 |
| 2014-11-20 | Open-market buy | 76,923 | $3.24 | 1,156,436 |
| 2014-11-20 | Open-market buy (derivative) | 76,923 | $0.01 | 76,923 |
| 2014-11-20 | Open-market buy | 76,923 | $3.24 | 1,129,036 |
| 2014-11-14 | — | — | — | 1,079,513 |
| 2014-11-14 | — | — | — | 1,052,113 |
| 2014-11-14 | — | — | — | 2,539 |
| 2014-11-14 | — | — | — | 11,243 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.